The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly.
Bernabeu I, Alvarez-Escolá C, Quinteiro C, Lucas T, Puig-Domingo M, Luque-Ramírez M, de Miguel-Novoa P, Fernandez-Rodriguez E, Halperin I, Loidi L, Casanueva FF, Marazuela M.
Bernabeu I, et al.
J Clin Endocrinol Metab. 2010 Jan;95(1):222-9. doi: 10.1210/jc.2009-1630. Epub 2009 Oct 22.
J Clin Endocrinol Metab. 2010.
PMID: 19850678